Adenosine A1R/A3R (Adenosine A1 and A3 Receptor) Agonist AST-004 Reduces Brain Infarction in a Nonhuman Primate Model of Stroke.
Theodore E ListonAldric HamaJohannes BoltzeRussell B PoeTakahiro NatsumeIkuo HayashiHiroyuki TakamatsuWilliam S KorinekJames D LechleiterPublished in: Stroke (2021)
These findings suggest that administration of AST-004 and combined A1R/A3R agonism in the brain are efficacious pharmacological interventions in acute ischemic stroke and warrant further clinical evaluation.